26 March 2015 EMA CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation) - Chemotherapy-induced nausea and vomiting - Document - PDFSEARCH.IO

First Page	Meta Content
	26 March 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation) Add to Reading List Document Date: 2015-03-27 08:09:02 Open Document File Size: 72,29 KB Share Result on Facebook City London / / Company Helsinn Birex Pharmaceuticals Ltd. / / Country United Kingdom / / Facility Canary Wharf / / IndustryTerm medicinal product / peripheral nervous systems / / MedicalCondition acute and delayed nausea / vomiting / moderately emetogenic cancer / fatigue / highly emetogenic cisplatin-based cancer / headache / constipation / / MedicalTreatment chemotherapy / / Organization Committee for Medicinal Products for Human Use / European Union / European Medicines Agency / contact An / European Commission / / / Product cisplatin / / PublishedMedium the European / / Technology chemotherapy / / URL www.ema.europa.eu/contact / / SocialTag Oncology Neuropeptides Neurotransmitters Lactams Palonosetron Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Substance P Chemotherapy Medicine

26 March 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)Add to Reading List